According to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who might be at increased risk.
The analysis examines MPX vaccine eligibility policies, compared to criteria recommended by the Centers for Disease Control and Prevention (CDC), in the 50 states, Washington, DC, and five cities that receive vaccines from the federal government (Chicago, Houston, Los Angeles, New York City, and Philadelphia) as of Sept. 12.
KFF finds that vaccine eligibility varies significantly across states, with several, including Illinois, Indiana, Maryland, and New Mexico, appearing to lack clear criteria or information about who is eligible or where to get vaccinated.
Key findings include:
The significant variation in MPX eligibility across the country means that people who are at high risk of contracting the virus may have access to vaccination in one state or city, while someone with a similar risk profile in a different region would not. Further, information about who can get vaccinated and where to find vaccines is sometimes sparse. This kind of variation could have an impact on infection rates as well as how equitable the vaccine roll-out is, particularly as new MPX cases are more concentrated among men of color who have sex with men.